Posted by Michael Wonder on 29 Jul 2020
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
29 July 2020 - Both companies are committed to making their COVID-19 vaccine candidate affordable and available globally.
Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine.
The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant technology.
